Why the study?
Does tight glucose control improve morbidity and mortality in patients presenting with acute myocardial infarction?
Does tight glucose control improve morbidity and mortality in patients presenting with acute myocardial infarction?
Contemporary evidence suggests persistent hyperglycemia negatively impacts AMI patients, though lack of convincing clinical data has led to poor implementation of glucose targets.
Hyperglycaemia, in both diabetic and nondiabetic patients, has a significant negative impact on the morbidity and mortality of patients presenting with an Acute Myocardial Infarction (AMI). Contemporary evidence indicates that persistent hyperglycaemia after initial hospital admission continues to exert negative effects on AMI patients. There have been a number of studies demonstrating the benefit of tight glucose control in patients presenting with AMI, but a lack of convincing clinical data ha s led to loose guidelines and poor implementation of glucose targets for this group of patients.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: